Alsulami Manal O, Alharbi Nada M, Alsulami Dania W, Almaghrabi Sahar J, Albaradei Hadeel A, Alhozali Amani M
College of Medicine, King Abdulaziz University, Jeddah, SAU.
Endocrinology, King Abdulaziz University Hospital, Jeddah, SAU.
Cureus. 2022 Sep 2;14(9):e28686. doi: 10.7759/cureus.28686. eCollection 2022 Sep.
Thyroid hormones have substantial effects on blood pressure (BP) and renal function as they influence the glomerular filtration rate (GFR). Maintaining healthy BP and preventing premature development of nephropathy necessitates taking steps.
The aim of this study was to explore the association between BP, GFR, and thyroid-stimulating hormone (TSH) levels in hypothyroid patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
A retrospective record review study of all hypothyroid patients from June 1, 2010 to June 6, 2020. The medical records of 1,181 adult patients were reviewed, and 157 met the criteria. All patients aged >18 years who were diagnosed with hypothyroidism and were on levothyroxine therapy, were included in this study.
More than half of the participants were female (83.4%). There was no significant correlation between TSH and systolic BP (P= 0.6), or TSH and diastolic BP (P=0.8), while there was a positive correlation between TSH and creatinine (r=0.4, P=0.001) and a negative correlation between TSH and GFR (r=-0.2, P=0.01).
We found no association between BP and TSH, while creatinine correlated directly and GFR inversely with TSH. Follow-up renal function should be a target for physicians in hypothyroid patients to prevent premature complications.
甲状腺激素对血压(BP)和肾功能有显著影响,因为它们会影响肾小球滤过率(GFR)。采取措施维持健康的血压并预防肾病的过早发展是必要的。
本研究的目的是探讨沙特阿拉伯吉达阿卜杜勒阿齐兹国王大学医院甲状腺功能减退患者的血压、肾小球滤过率(GFR)和促甲状腺激素(TSH)水平之间的关联。
对2010年6月1日至2020年6月6日期间所有甲状腺功能减退患者进行回顾性记录审查研究。审查了1181名成年患者的病历,其中157名符合标准。本研究纳入了所有年龄大于18岁、被诊断为甲状腺功能减退且正在接受左甲状腺素治疗的患者。
超过一半的参与者为女性(83.4%)。促甲状腺激素(TSH)与收缩压(P = 0.6)或促甲状腺激素与舒张压(P = 0.8)之间无显著相关性,而促甲状腺激素与肌酐之间呈正相关(r = 0.4,P = 0.001),促甲状腺激素与肾小球滤过率(GFR)之间呈负相关(r = -0.2,P = 0.01)。
我们发现血压与促甲状腺激素之间无关联,而肌酐与促甲状腺激素呈正相关,肾小球滤过率与促甲状腺激素呈负相关。随访肾功能应成为甲状腺功能减退患者医生预防过早并发症的目标。